Huamin Wang is a professor of pathology specializing in gastrointestinal pathology, a physician-scientist, and the chief of gastrointestinal pathology. He received his MD from Tongji Medical University in Wuhan, China, and his PhD in Biochemistry and Molecular Biology from the University of Texas. He then completed a residency program and fellowship at the University of Texas. He joined the MD Anderson Cancer Center in 2004. He has a strong passion for innovative translational research, mainly focused on pancreatic cancer, and he has served as principal investigator (PI), pathology core leader/Core PIs, or co-PI for more than 40 research grants, including SPOREs, P01s, U01s, many other NIH/NCI grants, and grants from various foundations. His laboratory research, funded by two NIH/NCI R01 grants, has been focused on many aspects of pancreatic cancer, including protein kinase and phosphatase alterations, novel pathophysiologic mechanisms, and the development of new biomarkers. He has also been actively involved in the clinicopathologic studies on histopathologic predictors and molecular biomarkers in pancreatic cancer patients who received neoadjuvant therapies and in treatment-naïve pancreatic cancer patients. He has been the co-director of the pancreatic cancer tumor bank at MDACC since 2004 and has enjoyed productive collaborations with many elite scientists and clinicians on pancreatic cancer research both inside MDACC and across the United States.